Odisha CM launches 55 road safety projects worth Rs 576 crore
Inaugurating the Zero Accident Day and Road Safety Week programme here, the chief minister said accidents not only affect individuals and families but also have a significant impact on the state's economy.
He said road accident-related deaths have become a significant problem in India with 75.2 per cent of such fatalities caused by speeding.
'Drivers often forget the golden rule of driving: 'Speed thrills, but it also kills'. Wrong-side driving, drunk driving and using mobile phones while driving contribute to accident-related deaths. People should be cautious and avoid these mistakes to ensure safety of their lives as well as others,' he said.
The Zero Accident Day campaign will continue till June 28. It is being conducted in collaboration with IIT-Madras. On this occasion, Majhi launched 11 automated driving testing systems (ADTS) in various districts with an investment of Rs 24 crore. He also launched the second phase of the Driving Electronic Enforcement to Save Human Lives (DISHA) project worth Rs 215 crore, which will cover 485 km of national and state highways.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
23 minutes ago
- New Indian Express
460 TB patients in Madurai await monthly aid under government scheme
MADURAI: Over 400 tuberculosis (TB) patients in Madurai district have expressed disappointment after failing to receive their entitled financial assistance under the Central government's Nikshay Poshan Yojana (NPY), a scheme that provides Rs 1,000 per month for nutritional support to TB patients for a period of six months. According to official records, 2,716 patients were notified as TB cases in Madurai district between January and July 2025. Of these, 2,252 were registered under the NPY to receive Rs 6,000 in two instalments. However, only 1,790 patients have received the benefit so far, while 462 are still awaiting disbursal. Muthurengama (48), a resident of Avaniyapuram said, 'I have been undergoing treatment for TB for a few months now and have been diligently following the medication schedule. The doctors assured us that we would receive Rs 1,000 per month under this scheme. I have submitted my bank account details, but even after several months, I haven't received a single rupee. Many others are facing the same issue too.'
Hans India
an hour ago
- Hans India
ONGC to fund cancer infrastructure in three hospitals
Kakinada: Oil and Natural Gas Corporation (ONGC) has agreed to provide financial support for the installation of advanced radiation machines for cancer treatment at government hospitals in Kakinada, Guntur, and Kadapa districts. The initiative, costing Rs 48 crore, will be funded under ONGC's Corporate Social Responsibility (CSR) programme. The decision was taken following a meeting between Union Minister for Petroleum and Natural Gas Hardeep Singh Puri and a delegation comprising Dr P Chandrasekhar, Union Minister of State for Rural Development and Communications, and Rajya Sabha MP Sana Satish Babu. During the meeting held in New Delhi on Thursday, the leaders sought central assistance in strengthening the fight against cancer in Andhra Pradesh. Speaking to 'The Hans India', MP Satish Babu said that the proposal involved the procurement of three state-of-the-art radiation therapy machines, each worth approximately Rs 16 crore. Minister Puri responded positively and initiated discussions with ONGC officials, leading to the company's commitment to provide the equipment. He also said that these machines will play a crucial role in the early detection and effective radiation treatment of cancer. The equipment will soon be installed at the respective government hospitals, significantly enhancing oncology infrastructure and care in the region.
News18
an hour ago
- News18
FTA With UK Set To Slash MedTech Duties, Accelerate Pharma Exports
Last Updated: India's exports of medical devices to the UK rose to Rs 1,015 crore in 2024, up 13% from 2023. Imports surged even faster—from Rs 1,682 crore to Rs 2,295 crore—a 36% rise The signing of the India-UK Free Trade Agreement (FTA) marks a major breakthrough in strengthening bilateral ties, with significant implications for India's pharmaceutical and medical technology sectors. Industry leaders have welcomed the deal as a catalyst for export growth, regulatory cooperation, and foreign investment. India's pharma industry sees the United Kingdom as a strategic market, and stakeholders expect the FTA to further boost confidence among investors and global partners. 'The India-UK Free Trade Agreement (FTA) marks a pivotal milestone in economic cooperation, particularly in the pharmaceutical sector," said Namit Joshi, chairman of the pharmaceutical export body under the ministry of commerce and industry, Pharmexcil. 'With India's pharmaceutical exports to the UK reaching $914 million in FY24, the agreement strengthens supply chains, enhances access to affordable medicines, and drives foreign direct investment. This partnership paves the way for collaborations in bulk drug imports, contract development and manufacturing organisation (CDMO), and joint research." Medical device manufacturers, too, anticipate tangible benefits. Rajiv Nath, forum coordinator of the Association of Indian Medical Device Industry (AiMeD), welcomed the development but stressed the need to address long-standing non-tariff barriers. 'We congratulate the Indian government and Prime Minister on signing the Free Trade Agreement with the UK and await the details," Nath said. While medical devices imported into the UK were already duty-free, Indian exporters have faced challenges with regulatory approvals. 'We sought recognition of Indian CDSCO regulatory approval or QCI's voluntary Indian certification for medical devices to fast-track regulatory approvals by the UK's MHRA. We look forward to an update on whether these proposals were included," Nath added. At the same time, he urged vigilance to prevent misuse of the agreement through third-country routing. 'There is a need for strict monitoring and verification of Rules of Origin to prevent the misuse of the FTA by the possibility of routing third-country products through the UK as purportedly UK-made goods. We welcome UK-made medical products into India via this FTA," said Nath. Trade data shows upward trend India's exports of medical devices to the UK rose to Rs 1,015 crore in 2024, up 13% from the previous year. Imports surged even faster—from Rs 1,682 crore to Rs 2,295 crore—marking a 36% increase. Nath explained, 'Post-FTA, both are expected to accelerate. Import duties levied by India, mostly at 7.5%, will hopefully be phased down. Let's see what the fine print says." FTA also expected to benefit labour-intensive sectors While the pharma and med-tech sectors are expected to be among the key beneficiaries, the FTA's potential spans wider. Harish Ahuja, chairman, FICCI Foreign Trade and Trade Facilitation Committee, called it a 'historic step" in boosting India's export competitiveness. 'The agreement is poised to boost India's export competitiveness, particularly in labour-intensive sectors including textiles and apparel," he said. 'This milestone achieved…will create new prospects for the domestic manufacturing industry, accelerate export growth, and deepen India's integration in global value chains." Next steps: Industry awaits fine print Industry players now await the release of the full text of the agreement to understand timelines for tariff reductions, provisions on regulatory alignment, and safeguards. But the consensus is clear: the India-UK FTA is expected to unlock a new phase of growth in life sciences, innovation, and trade. view comments First Published: July 25, 2025, 07:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
